These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26342774)

  • 1. Chlorambucil gemcitabine conjugate nanomedicine for cancer therapy.
    Fan M; Liang X; Li Z; Wang H; Yang D; Shi B
    Eur J Pharm Sci; 2015 Nov; 79():20-6. PubMed ID: 26342774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
    Raoof M; Corr SJ; Zhu C; Cisneros BT; Kaluarachchi WD; Phounsavath S; Wilson LJ; Curley SA
    Nanomedicine; 2014 Aug; 10(6):1121-30. PubMed ID: 24650884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects.
    El-Sheikh SMA; Khairy MH; Osama E; Metwally MMM; Galal AAA
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):631-643. PubMed ID: 33104848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
    Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
    Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy.
    Camp ER; Wang C; Little EC; Watson PM; Pirollo KF; Rait A; Cole DJ; Chang EH; Watson DK
    Cancer Gene Ther; 2013 Apr; 20(4):222-8. PubMed ID: 23470564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated microRNA by gemcitabine prodrug for cancer treatment.
    Zhang HT; Sun J; Yan Y; Cui SH; Wang H; Wang CH; Qiu C; Chen X; Ding JS; Qian HG; Wang JC; Zhang Q
    J Control Release; 2019 Dec; 316():317-330. PubMed ID: 31733293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
    Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
    Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squalenoyl gemcitabine nanomedicine overcomes the low efficacy of gemcitabine therapy in pancreatic cancer.
    Réjiba S; Reddy LH; Bigand C; Parmentier C; Couvreur P; Hajri A
    Nanomedicine; 2011 Dec; 7(6):841-9. PubMed ID: 21419876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome-like nanocapsules of dual drug-tailed betaine for cancer therapy.
    Fang S; Niu Y; Zhang W; Zhang Y; Yu L; Zhang Y; Li X
    Int J Pharm; 2015 Sep; 493(1-2):460-5. PubMed ID: 26256150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and mechanistic-insight into the anti-proliferative potential of PLGA-gemcitabine conjugate.
    Khare V; Kour S; Alam N; Dubey RD; Saneja A; Koul M; Gupta AP; Singh D; Singh SK; Saxena AK; Gupta PN
    Int J Pharm; 2014 Aug; 470(1-2):51-62. PubMed ID: 24810239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-gemcitabine: a new gemcitabine prodrug for treating cancer.
    Dasari M; Acharya AP; Kim D; Lee S; Lee S; Rhea J; Molinaro R; Murthy N
    Bioconjug Chem; 2013 Jan; 24(1):4-8. PubMed ID: 23237198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
    Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
    Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy.
    Bui DT; Nicolas J; Maksimenko A; Desmaële D; Couvreur P
    Chem Commun (Camb); 2014 May; 50(40):5336-8. PubMed ID: 24185552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine.
    Zhao C; Xue X; Li G; Sun C; Sun C; Qu X; Li W
    Chem Biol Drug Des; 2012 Sep; 80(3):479-88. PubMed ID: 22642666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy.
    Huang P; Wang D; Su Y; Huang W; Zhou Y; Cui D; Zhu X; Yan D
    J Am Chem Soc; 2014 Aug; 136(33):11748-56. PubMed ID: 25078892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin induces apoptosis and enhances gemcitabine therapeutic efficacy against gemcitabine-resistant cancer cells.
    Liu ZJ; Xu W; Han J; Liu QY; Gao LF; Wang XH; Li XL
    Anticancer Drugs; 2020 Aug; 31(7):684-692. PubMed ID: 32282368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-circulating and liver-targeted nanoassemblies of cyclic phosphoryl N-dodecanoyl gemcitabine for the treatment of hepatocellular carcinoma.
    Du L; Zhang B; Lei Y; Wang S; Jin Y
    Biomed Pharmacother; 2016 Apr; 79():208-14. PubMed ID: 27044830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
    Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
    Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.